Pelvic & vaginal health

Mirabegron vs. Oxybutynin: Comparing OAB Medicines

Save

Oxybutynin and mirabegron treat overactive bladder with similar, modest benefit, so side effects usually decide. Oxybutynin brings dry mouth and constipation and more caution over age 65, while mirabegron spares those but may raise blood pressure. Cost and your other medicines also matter, and both work best alongside pelvic floor training.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

How do these two overactive bladder medicines work?

Overactive bladder happens when the bladder muscle squeezes before it is full, driving urgency, frequency, and sometimes leaks. Oxybutynin belongs to the antimuscarinic (anticholinergic) class, which blocks the nerve signals that trigger those unwanted squeezes 1. Mirabegron works the opposite way, as a beta-3 agonist that relaxes the bladder so it can hold more urine 1. According to a 2018 AHRQ systematic review, both classes reduce urgency and leakage more than a dummy pill, but the average benefit is modest, often a matter of a few fewer trips or accidents a day 2. Most people see the most gain when medicine is paired with pelvic floor exercises or bladder training rather than used alone.

Which one causes fewer side effects?

Side effects are the main reason people prefer one drug over the other. Oxybutynin's antimuscarinic action commonly causes dry mouth, constipation, and blurred vision, and dry mouth alone leads roughly 1 in 5 people to abandon the medicine 2. Extended-release, patch, and gel versions ease that somewhat. Mirabegron sidesteps dry mouth and constipation, which makes it appealing, but it can raise blood pressure, so clinicians usually check readings within the first few weeks and avoid it when blood pressure runs high 1. According to ACOG's practice guideline, the choice weighs these trade-offs against a person's other conditions and medicines 1. Combining a low amount of each is sometimes used when one alone falls short.

Does age or other health conditions change the pick?

Age and coexisting conditions shift the balance more than many people expect. In women over 65, antimuscarinics like oxybutynin carry extra caution because the same nerve-blocking effect adds to a person's total anticholinergic burden, which has been linked with memory and fall concerns 1. Mirabegron is often favored in this group for that reason, though blood pressure still needs watching 2. Narrow-angle glaucoma, constipation-prone bowels, or several other anticholinergic medicines also push toward mirabegron. According to the 2018 AHRQ review, head-to-head quality-of-life differences between the two remain small, so individual tolerance tends to guide the final choice 2. A clinician can map your full medicine list before either is started.

What else shapes an overactive bladder over a lifetime?

Bladder symptoms are not fixed; they shift across a woman's life. Urgency can first appear in the perimenopausal years and often intensifies afterward, because falling estrogen thins the tissues of the bladder and urethra as part of the genitourinary syndrome of menopause, which affects more than 1 in 2 postmenopausal women 3. For some, vaginal estrogen eases urgency enough that oral medicine matters less 3. Weight, caffeine, constipation, and fluid timing all influence symptoms too, which is why lifestyle steps and pelvic floor training usually come first 4. According to a 2018 Cochrane review, supervised pelvic floor muscle training over about 12 weeks helps many women, with or without medicine 4. Learning your overactive bladder symptoms makes any drug trial easier to judge.

When an overactive bladder needs a clinician

A clinician's input matters most when self-help and a first medicine have not settled things. New urgency that comes with blood in the urine, pain, fever, or a sudden change in bowel or bladder control deserves prompt evaluation rather than another over-the-counter fix. Urgency can also travel with pelvic organ prolapse, which about 1 in 8 women have surgery for by age 80, so a pelvic exam can change the plan 5. If pills disappoint, options such as bladder Botox or nerve stimulation open up. Gale can help you prepare for that conversation, including which symptoms and past medicines to mention.

Common questions

Neither is clearly stronger. In studies they reduce overactive bladder symptoms by similar, modest amounts, so the decision usually rests on side effects, blood pressure, cost, and your other medicines rather than on raw effectiveness.

Its anticholinergic action blocks nerve signals not only in the bladder but also in glands that make saliva, tears, and digestive fluid. That is why dry mouth, constipation, and blurred vision are common, and why patch or gel forms are sometimes gentler.

Sometimes. When one medicine alone does not fully control urgency, clinicians occasionally combine a beta-3 agonist with an antimuscarinic. Whether that fits depends on blood pressure, other conditions, and how each was tolerated on its own.

Usually. Lifestyle changes and pelvic floor training come first, then oral medicines, and third-line options like bladder Botox or nerve stimulation follow if symptoms persist. Some people move through these steps quickly when side effects or results disappoint.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

When bladder symptoms need a closer look

  • Blood in the urine, especially with new urgency, is a reason to seek clinician review.
  • Fever, back or side pain, or feeling generally unwell with bladder symptoms is a reason to seek same-day care.
  • A sudden loss of bladder or bowel control with numbness or leg weakness is a reason to seek emergency care.
  • New urgency that does not improve after a fair trial of one medicine is a reason to revisit your clinician.

A sudden loss of bladder or bowel control with new numbness, leg weakness, or severe back pain can signal a spinal emergency; call 911 or go to the nearest emergency room right away.

This article is general health education, not medical advice. Whether oxybutynin, mirabegron, or another approach fits you depends on your health history and is a decision to make with a primary care clinician or gynecologist.

References

  1. 1.American College of Obstetricians and Gynecologists (2015). ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001148Treatment sequencing for urinary incontinence and overactive bladder, antimuscarinic versus beta-3 agonist drug choice, dry-mouth and cardiovascular trade-offs, and caution with anticholinergic burden in older women
  2. 2.Balk E, Adam GP, Kimmel H, Rofeberg V, Saeed I, Jeppson P, Trikalinos T (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. Agency for Healthcare Research and Quality (AHRQ). PMID 30516945Comparative-effectiveness evidence that antimuscarinics and mirabegron each modestly outperform placebo for urinary incontinence and overactive bladder, with small quality-of-life differences between them and distinct harm profiles including dry mouth
  3. 3.The North American Menopause Society (Menopause Society) (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000001609Genitourinary syndrome of menopause affects more than half of postmenopausal women and includes urinary urgency and frequency from falling estrogen, which vaginal estrogen can help
  4. 4.Dumoulin C, Cacciari LP, Hay-Smith EJC (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005654.pub4Supervised pelvic floor muscle training improves or cures urinary incontinence in many women and is a first-line, low-risk option used with or before medicines
  5. 5.American College of Obstetricians and Gynecologists (2019). Pelvic Organ Prolapse: ACOG Practice Bulletin, Number 214. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003519Pelvic organ prolapse commonly coexists with urinary urgency and incontinence, and about 1 in 8 women undergo surgery for prolapse or incontinence by age 80

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy